NEOBIANACID

NEOBIANACID PEDIATRIC 36 GRANULAR SACHETS

NEOBIANACID PEDIATRIC 36 GRANULAR SACHETS

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

NeoBianacid Pediatric

Description
NeoBianacid Pediatric is a medical device based on plant molecular complexes and natural minerals that protect and soothe the gastroesophageal mucosa, helping to rapidly counteract the sensation of acidity, burning, pain, and the typical symptoms of irritation and inflammation of the mucosa. Neobianacid Pediatric works by reproducing the physiological defense mechanisms of the gastroesophageal tract thanks to Poliprotect, a molecular complex developed by Aboca, and the flavonoid fraction, which protect the mucosa from gastric juices and counteract irritation caused by free radicals. Specifically, Poliprotect forms a barrier film (a polysaccharide component with mucoadhesive properties) and provides a local buffering effect (a mineral component from Limestone and Nahcolite). NeoBianacid Pediatric is indicated in children over 1 year of age for the treatment of problems related to gastroesophageal reflux disease, such as regurgitation, vomiting, and abdominal pain. It is also indicated for the treatment of functional dyspepsia, characterized by one or more of the following symptoms: difficulty digesting food, feeling of postprandial fullness, early satiety, epigastric pain or burning.

Ingredients
-Poliprotect: synergistic molecular complex of polysaccharides* (obtained from Aloe vera, Malva sylvestris and Althaea officinalis) and natural minerals Limestone and Nahcolite titrated in polysaccharides (molecular weight >20,000 daltons) ≥7.6% (20 mg per granular sachet).
-Flavonoid fraction* (obtained from Matricaria recutita and Glycyrrhiza glabra).
-Also contains: cane sugar*, natural flavoring.
*Ingredient from organic farming.

How to use
Dissolve the contents of one sachet in a little water after main meals and before bed. A maximum daily dosage of 4 sachets is recommended for children aged 1 to 3 years and 6 sachets for children aged 4 to 6 years. The product can also be taken for extended periods.

Warnings
Do not use if you have a known hypersensitivity or allergy to one or more components. If symptoms persist, consult your pediatrician. It is recommended to take the product at least two hours after taking medications whose effectiveness may be reduced by concomitant calcium administration.

Conservation
Store in a cool, dry place, away from heat and light. Keep out of reach of children. The expiration date applies to unopened and properly stored product.

Format
Pack of 36 single-dose granular sachets of 775 mg each.

Cod. ANAPEGRX

NEOBIANACID

NEOBIANACID PEDIATRIC 36 GRANULAR SACHETS

NEOBIANACID PEDIATRIC 36 GRANULAR SACHETS

MINSAN code: 980430577
EAN Code: 8032472021360
Previous price: €16,06
Regular price €16,06
Regular price €0,00 Sale price €16,06
-% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.